IPO

NASDAQ STOCKHOLM WELCOMES
ISOFOL MEDICAL TO
FIRST NORTH PREMIER

Read More

Candidate

MODUFOLIN®
A BETTER AND MORE EFFICIENT TREATMENT

Read more

Common treatment

Folates are the most

commonly used drugs in cancer

treatment today

Read more

Situation of today

A majority of patients do not
fully benefit from their
folate treatment today

Read more

About Modufolin

Modufolin® holds the
potential to replace all
folates in cancer treatments

Read more

Devlopment Status

US and EU regulatory
authorities have endorsed the
Modufolin® development plan

Read more

Previous

Next

Startpage